School of Chemistry and Chemical Engineering , Harbin Institute of Technology , No. 92, West Dazhi Street , Nangang District, Harbin 150001 , China.
College of Food Science , Northeast Agricultural University , Harbin 150030 , China.
ACS Appl Mater Interfaces. 2019 Aug 21;11(33):29498-29511. doi: 10.1021/acsami.9b07404. Epub 2019 Aug 7.
Supramolecular photosensitizers based on nanosized drug delivery or combination therapy have been proposed as a promising strategy for cancer treatment. Herein, we screen and develop a series of multifunctional single-component, carrier-based, natural small-molecule sterols (ergosterol, β-sitosterol, and stigmasterol) that simultaneously possess self-assembly ability, anticancer activity, and better biocompatibility and biodegradability to deliver photosensitizer chlorin e6 (Ce6) for significantly combined and safe antitumor photodynamic therapy. The resultant ergosterol-Ce6 nanodrugs (Ergo-Ce6 NPs) have enhanced reactive oxygen species (ROS) generation by promoting type I photoreactions, while Ce6 mainly exists in the monomer state in assembled Ergo-Ce6 NPs via intermolecular π-π stacking and hydrophobic interactions. In addition, with the improved water solubility and stability and higher intercellular ROS generation, Ergo-Ce6 NPs show remarkably in vitro phototoxicity with approximately 73% and 92% cell inhibition ratios to 4T1 and MCF-7 cancer cells at a rather low dosage of Ce6 (1 μg/mL), respectively. Moreover, the excellent tumor targeting ability of Ergo NPs and prolonged blood circulation ensure a quick tumor accumulation of Ergo-Ce6 NPs, resulting in a significantly enhanced in vivo anticancer efficiency of 86.4%, higher than that of the anticancer ability of Ergo NPs (51.0%) or Ce6 PDT alone (59.5%). Furthermore, the resulting nanodrugs have better biocompatibility and biodegradability and low in vivo toxicity, and all of which ensure a safe tumor therapy. This study provides a promising perspective to develop more natural self-assembled biological small-molecule nanomaterials for the fabrication of novel medicinal photosensitizers for clinical application in the future.
基于纳米药物递送或联合治疗的超分子光敏剂已被提议作为癌症治疗的一种有前途的策略。在此,我们筛选和开发了一系列多功能单组分、基于载体的天然小分子甾醇(麦角固醇、β-谷甾醇和豆甾醇),它们同时具有自组装能力、抗癌活性和更好的生物相容性和生物降解性,用于递送光敏剂氯代叶绿素 e6(Ce6),以实现显著的联合和安全的光动力治疗。所得的麦角固醇-Ce6 纳米药物(Ergo-Ce6 NPs)通过促进 I 型光反应增强了活性氧(ROS)的产生,而 Ce6 主要以单体状态存在于组装的 Ergo-Ce6 NPs 中,通过分子间π-π堆积和疏水相互作用。此外,由于提高了水溶性和稳定性以及更高的细胞内 ROS 生成,Ergo-Ce6 NPs 在体外表现出显著的光毒性,在相当低的 Ce6(1μg/mL)剂量下,对 4T1 和 MCF-7 癌细胞的细胞抑制率分别约为 73%和 92%。此外,Ergo NPs 的优异肿瘤靶向能力和延长的血液循环确保了 Ergo-Ce6 NPs 的快速肿瘤积累,从而显著提高了体内抗癌效率 86.4%,高于 Ergo NPs(51.0%)或 Ce6 PDT 单独(59.5%)的抗癌能力。此外,所得的纳米药物具有更好的生物相容性和生物降解性和低体内毒性,所有这些都确保了安全的肿瘤治疗。本研究为开发更多天然自组装生物小分子纳米材料用于制备新型药用光敏剂以用于未来的临床应用提供了有前途的视角。